Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, May 10, 2023
[ Wed, May 10th 2023
] - WOPRAI
[ Wed, May 10th 2023
] - WOPRAI
[ Wed, May 10th 2023
] - WOPRAI
[ Wed, May 10th 2023
] - WOPRAI
[ Wed, May 10th 2023
] - WOPRAI
[ Wed, May 10th 2023
] - WOPRAI
[ Wed, May 10th 2023
] - WOPRAI
[ Wed, May 10th 2023
] - WOPRAI
[ Wed, May 10th 2023
] - WOPRAI
[ Wed, May 10th 2023
] - WOPRAI
[ Wed, May 10th 2023
] - WOPRAI
[ Wed, May 10th 2023
] - WOPRAI
[ Wed, May 10th 2023
] - WOPRAI
[ Wed, May 10th 2023
] - WOPRAI
[ Wed, May 10th 2023
] - WOPRAI
[ Wed, May 10th 2023
] - WOPRAI
[ Wed, May 10th 2023
] - WOPRAI
[ Wed, May 10th 2023
] - WOPRAI
[ Wed, May 10th 2023
] - WOPRAI
[ Wed, May 10th 2023
] - WOPRAI
[ Wed, May 10th 2023
] - WOPRAI
[ Wed, May 10th 2023
] - WOPRAI
[ Wed, May 10th 2023
] - WOPRAI
[ Wed, May 10th 2023
] - WOPRAI
[ Wed, May 10th 2023
] - WOPRAI
[ Wed, May 10th 2023
] - WOPRAI
Uy Ear Maintained (ARQT) at Strong Buy with Decreased Target to $57 on, May 10th, 2023
Uy Ear of Mizuho, Maintained "Arcutis Biotherapeutics, Inc." (ARQT) at Strong Buy with Decreased Target from $61 to $57 on, May 10th, 2023.
Uy has made no other calls on ARQT in the last 4 months.
There are 3 other peers that have a rating on ARQT. Out of the 3 peers that are also analyzing ARQT, 0 agree with Uy's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Uy
- Serge Belanger of "Needham" Reiterated at Strong Buy and Held Target at $24 on, Wednesday, April 19th, 2023
- Gregory Fraser of "Truist Securities" Maintained at Strong Buy with Decreased Target to $45 on, Wednesday, March 29th, 2023
- Vikram Purohit of "Morgan Stanley" Maintained at Buy with Decreased Target to $50 on, Wednesday, March 1st, 2023
